Susan Shamimi-Noori, MD

Program Director
University of Pennsylvania, United States

Presentation(s):

• 70 - Utility of Alpha-Fetoprotein (AFP) monitoring after Y-90 radioembolization of hepatocellular carcinoma in non-AFP producers

  Monday, March 31, 2025
  12:10 PM – 1:10 PM CT

• Premedication with NK-1 antagonists and COX-2 inhibitors improves same day discharge rates following chemoembolization for hepatocellular carcinoma and neuroendocrine liver metastasis

  Tuesday, April 1, 2025
  4:21 PM – 4:30 PM CT

• Looking Back and Moving Forward: Senior IR resident Perspectives on the Training Process

  Wednesday, April 2, 2025
  11:15 AM – 11:24 AM CT